LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

BioPharma DiveIncyte to buy blood disorder drug in possibly $2B deal

FierceBiotechClinical-stage cancer biotech Treeline sees path to public markets via reverse merger

FierceBiotechADA: Dexcom CGM shows benefit in non-insulin diabetes patients

BioPharma DiveJ&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for up to $1B

Endpoints NewsTreeline to go public via reverse merger with Standard BioTools

BioPharma DiveADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option

FierceBiotechResmed snaps up Noctrix Health in $340M sleep tech deal

BioWorldBiggest gainers and losers for June 1-5, 2026

Endpoints NewsJ&J makes $1B move for Firefly Bio, Carolyn Bertozzi's twist on ADCs in KRAS field

FierceBiotechJ&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Endpoints NewsGSK inks multi-target pact with Engitix; Sangamo considers strategic options

Endpoints NewsTango plans Phase 3 pancreatic cancer study after combo success